Managing hypertension: A question of STRATHE

Journal of Human Hypertension

Volumn 19, Issue , 2005, Pages S3-S7

  Zannad, F ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Indapamide; Low dose combination; Management strategy; Perindopril; Strathe

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LISINOPRIL; LOSARTAN; PERINDOPRIL; PRETERAX; TRANDOLAPRIL; VALSARTAN; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BEHAVIOR MODIFICATION; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; LIFESTYLE; LOW DRUG DOSE; MONOTHERAPY; PATIENT ATTITUDE; PATIENT CARE; PRACTICE GUIDELINE; SIDE EFFECT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 21744458786     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001886     Document Type: Article

References (20)

1. Guidelines Committee. 2003 European Society of Hypertension European Society of Cardiology guide-lines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.
2. Chobanian AV, the National High Blood Pressure Education Program Coordinating Committee (2003). Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252.
3. World Health Organization (2003). 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983–1992.
4. Vivki L. Trends in prevalence, awareness, treatment, and control of hypertension in the adult US population. Hypertension 1995; 26: 60–69.
5. Dusing R, Weisser B, Mengden T, Vetter H. Changes in antihypertensive therapy — the role of adverse effects and compliance. Blood Press 1998; 7: 313–315.
6. Berlowitz DR. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957–1963.
7. Cushman WC. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trials (ALLHAT). J Clin Hypertens 2002; 4: 393–404.
8. Dahlőf B. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint Reduction in hypertension study (LIFE): a randomised trial against atenonol. Lancet 2002; 359: 995–1003.
9. Pepine CJ. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil- Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003; 290: 2805–2816.
10. Mourad J, on behalf of the investigators of the STRATHE trial (2004). Comparison of different therapeutic strategies in hypertension: a low-dose combination on perindopril/indapamide versus a sequential monotherapy or a stepped-care approach. J Hypertens 2004; 22: 2379–2386.
11. Waeber B. Very-low-dose combination: a first-line choice for the treatment of hypertension. J Hypertens 2003; 21(Suppl 3): S3–S10.
12. Myers MG. Fixed low-dose combination therapy in hypertension — a dose response study of perindopril and indapamide. J Hypertens 2000; 18: 317–325.
13. Laurent S. Very-low-dose combination of perindopril and indapamide: efficacy on blood pressure and targetorgan damage. J Hypertens 2003; 21(Suppl 3): S11–S18.
14. Neutel JM, Smith DHG, Weber MA. Low-dose combination therapy: an important first-line treatment in the management of hypertension. Am J Hypertens 2001; 14: 286–292.
15. Chanudet W, De Champvallins M. Antihypertensive efficacy and tolerability of low-dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension. Int J Clin Pract 2001; 55: 233–239.
16. Asmar RG, London GM, O’Rourke ME, Safar ME, for the REASON Project coordinators and investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient, a comparison with atenolol. Hypertension 2001; 38: 922–926.
17. Morgan T, Anderson A. Low-dose combination therapy with perindopril and indapamide compared with irbesartan. Clin Drug Invest 2002; 22: 553–560.
18. Mogensen CE. Effect of low-dose perindopril/indapamide on albuminuria in diabetes, Preterax in Albuminuria Regression: PREMIER. Hypertension 2003; 41: 1063–1071.
19. Mourad JJ, Balcher J, Blin P, Warzocha U, on behalf of the investigators of the PHASTE study. Conventional antihypertensive drug therapy does not prevent the increase of pulse pressure with age. Hypertension 2001; 38: 958–962.
20. Chalmers J, Castaigne A, Morgan T, Chastang C. Longterm efficacy of a new, fixed, very-low-dose angiotensin- converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients. J Hypertens 2000; 18: 327–337.